Join the Birth Control group to help and get support from people like you.
Birth Control News (Page 6)
Related terms: Fertility Control, Anticonception
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Five Years
DUBLIN and SAN FRANCISCO October 16, 2018 – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women’s health pharmaceutical company with a mis...
FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System
NEW YORK, Aug. 10, 2018 /PRNewswire/ – The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera™ (...
FDA Medwatch Alert: Taytulla (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) by Allergan: Recall - Due to Out of Sequence Capsules
ISSUE: Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of Taytulla and the first four days of therapy had four...
FDA Medwatch Alert: Essure Permanent Birth Control System by Bayer Healthcare: Announcement - FDA Restricts the Sale and Distribution
ISSUE: The FDA is aware that some women have received the Essure device without being adequately informed of Essure’s risks. In order for this device to meet reasonable assurance of safety and e...
Avion Pharmaceuticals Announces FDA Approval of Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) Oral Contraceptive
ATLANTA, Jan. 17, 2018 /PRNewswire/ – Avion Pharmaceuticals, LLC, the makers of the Prenate® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral ...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Four Years
August 6, 2017 – Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to...
FDA Medwatch Alert: Mibelas 24 Fe Chewable Tablets by Lupin Pharmaceuticals Inc.: Recall - Out of Sequence Tablets and Missing Expiry/Lot Information
ISSUE: Lupin Pharmaceuticals Inc. announced a recall of lot L600518, Exp 05/18 of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1 mg/0.02 mg chewable and ferrous fumarate 75 mg) Tablets ...
FDA Medwatch Alert: Essure Permanent Birth Control System by Bayer Healthcare: FDA Announcement - Label Changes
ISSUE: Essure labeling now includes the addition of a boxed warning and a Patient Decision Checklist, both intended to support patient counseling and understanding of benefits and risks associated...
FDA Approves Bayer's Kyleena (Levonorgestrel-Releasing Intrauterine System) for Prevention of Pregnancy for up to Five Years
WHIPPANY, N.J., Sept. 19, 2016 /PRNewswire/ – Bayer announced today that the U.S. Food and Drug Administration (FDA) approved Kyleena (levonorgestrel-releasing intrauterine system) 19.5 mg, a...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Three Years
DUBLIN and SAN FRANCISCO, Feb. 27, 2015 /PRNewswire/ – Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical...
Mylan Launches Xulane - First Generic Ortho Evra Patch
PITTSBURGH, April 16, 2014 /PRNewswire/ – Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Xulane (Norelgestromin / Ethinyl Estradiol...
Warner Chilcott Announces FDA Approval of Lo Minastrin Fe
DUBLIN, Ireland, July 25, 2013 – Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved Lo Minastrin Fe (norethindrone acetate and ethinyl...
FDA Medwatch Alert: Estarylla (norgestimate and ethinyl estradiol): Recall - Report of Placebo Tablet Present in Row of Active Tablets
ISSUE: Sandoz notified the public it is conducting a voluntary nationwide recall to the retailer level of one lot of its Estarylla (norgestimate and ethinyl estradiol) tablets in the US, following a...
FDA Approves Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy
JERUSALEM--(BUSINESS WIRE)--Mar. 29, 2013-- Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Quartette (levonorgestrel/ethinyl...
U.S. FDA Approves Bayer's Skyla (Levonorgestrel-Releasing Intrauterine System) 13.5 mg For Prevention Of Pregnancy For Up To Three Years
WAYNE, N.J., Jan. 9, 2013 /PRNewswire/ – Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Skyla (levonorgestrel-releasing intrauterine...
Further information
Related condition support groups
Emergency Contraception, Postcoital Contraception
Related drug support groups
Depo-Provera, Nexplanon, Provera, NuvaRing, Mirena, Implanon, levonorgestrel, Sprintec, Loestrin 24 Fe, Yasmin, Lo Loestrin Fe, medroxyprogesterone, Kyleena